Circular RNA circ_0021093 regulates miR-432/Annexin A2 pathway to promote hepatocellular carcinoma progression

被引:5
作者
Wang, Yong [1 ]
Xu, Wei [1 ]
Zu, Maoheng [1 ]
Xu, Hao [1 ]
机构
[1] Xuzhou Med Univ, Dept Intervent Radiol, Affiliated Hosp, 9 KunPeng Rd, Xuzhou 221000, Jiangsu, Peoples R China
关键词
circular RNA; circ_0021093; miR-432; Annexin A2; hepatocellular carcinoma; epithelial-mesenchymal transition; ANNEXIN A2; CANCER; PROLIFERATION; ASSOCIATION; GROWTH;
D O I
10.1097/CAD.0000000000001053
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is a major histological subtype of liver cancer cases. Previous studies showed that circular RNA (circRNA) circ_0021093 was upregulated in HCC, but the regulatory mechanism of circ_0021093 is still rare. The expression levels of circ_0021093, miR-432 and Annexin A2 (ANXA2) were analyzed by real-time quantitative PCR. The relationship between the overall survival time of HCC patients and circ_0021093 level was analyzed with Kaplan-Meier analysis. Cell proliferation, migration and invasion were examined with cell counting kit-8 and transwell assays. Western blot was used to assess the protein expression of epithelial-mesenchymal transition markers and ANXA2. In addition, loss- or gain-of-function experiments and dual-luciferase reporter assay were performed to probe the relationship between miR-432 and circ_0021093 or ANXA2. The influences of circ_0021093 silencing in vivo were measured by using xenograft models. Circ_0021093 was highly expressed in HCC tissues and cells, and its level was associated with poor prognosis of HCC patients. Functional experiments showed that knockdown of circ_0021093 repressed proliferation, migration and invasion in vitro and tumor growth in vivo by regulating miR-432, while upregulation of circ_0021093 reversed these results. Moreover, miR-432 negatively regulated ANXA2 expression in HCC, and introduction of ANXA2 could abolish overexpression of miR-432-induced effects on HCC cells. Collectively, circ_0021093 boosted HCC progression via regulating proliferation, migration and invasion of HCC cells by acting as competing endogenous RNA to sponge miR-432.
引用
收藏
页码:484 / 495
页数:12
相关论文
共 30 条
[1]   Non-coding RNA networks in cancer [J].
Anastasiadou, Eleni ;
Jacob, Leni S. ;
Slack, Frank J. .
NATURE REVIEWS CANCER, 2018, 18 (01) :5-18
[2]   Hepatocellular carcinoma: clinical frontiers and perspectives [J].
Bruix, Jordi ;
Gores, Gregory J. ;
Mazzaferro, Vincenzo .
GUT, 2014, 63 (05) :844-855
[3]  
Cai HJ, 2018, AM J TRANSL RES, V10, P1690
[4]   Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1 [J].
D'Angelo, Daniela ;
Palmieri, Dario ;
Mussnich, Paula ;
Roche, Magali ;
Wierinckx, Anne ;
Raverot, Gerald ;
Fedele, Monica ;
Croce, Carlo Maria ;
Trouillas, Jacqueline ;
Fusco, Alfredo .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (07) :E1128-E1138
[5]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Llovet, Josep M. ;
Bruix, Jordi .
LANCET, 2012, 379 (9822) :1245-1255
[6]   Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6 [J].
Gong, Yuhua ;
Mao, Jinzhong ;
Wu, Di ;
Wang, Xuemei ;
Li, Long ;
Zhu, Liang ;
Song, Rong .
CANCER CELL INTERNATIONAL, 2018, 18
[7]   ELECTRON-MICROSCOPIC EVIDENCE FOR THE CIRCULAR FORM OF RNA IN THE CYTOPLASM OF EUKARYOTIC CELLS [J].
HSU, MT ;
COCAPRADOS, M .
NATURE, 1979, 280 (5720) :339-340
[8]   MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review (vol 4, pg 143, 2012) [J].
Iorio, Marilena V. ;
Croce, Carlo M. .
EMBO MOLECULAR MEDICINE, 2017, 9 (06) :852-852
[9]   Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells [J].
Kim, Yong-Wan ;
Kim, Eun Young ;
Jeon, Doin ;
Liu, Juinn-Lin ;
Kim, Helena Suhyun ;
Choi, Jin Woo ;
Ahn, Woong Shick .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 :293-314
[10]   Circular RNAs in cancer: opportunities and challenges in the field [J].
Kristensen, L. S. ;
Hansen, T. B. ;
Veno, M. T. ;
Kjems, J. .
ONCOGENE, 2018, 37 (05) :555-565